JPRN-jRCT2031230195招募中2 期
A multi-center, placebo-controlled, randomized, double-blind phase 2 trial of foscenvivint in patients with decompensated cirrhosis related with HCV, HBV, or NASH
Haruyama Yuushi0 个研究点目标入组 93 人开始时间: 2023年7月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 93
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 < 75age old（—）
- 性别
- All
入选标准
- •1. Patients with decompansated cirrhosis (Child-Pugh class B: Score 7-9)
- •2. Patients with liver cirrhosis related with HCV, HBV, or NASH
- •3. Patients with performance Status: 0-2
- •4. Patients with serum albumin levels =<3.5 g/d
排除标准
- •1. Patients with decompansated cirrhosis of which cause is unknown
- •2. Patients with refractory ascites
- •3. Patients with complication or history of malignant tumor (within 3 years before screening, excepting the patients with no relapse of hepatocellular carcinoma during more than 1 year from surgical treatment etc.)
- •4. Patients with or have a history of serious allergies
研究者
相似试验
进行中（未招募）
1 期
A clinical study investigating Myramistin versus Placebo for acute pharyngitisAcute PharyngitisEUCTR2018-002543-28-DEMEGAINPHARM GmbH220
进行中（未招募）
1 期
A clinical study investigating Myramistin versus Placebo for acute pharyngitisAcute PharyngitisEUCTR2018-002543-28-ATMEGAINPHARM GmbH220
进行中（未招募）
1 期
A multi-centre, randomized, placebo-controlled, double-blind trial to assess the efficacy and safety of nitroglycerin sublingual powder on walking distance in a scheduled forced titration design in patients with peripheral arterial occlusive disease (PAOD) and intermittent claudication.Peripheral arterial occlusive disease (PAOD, femoro-popliteal stenosis) and intermittent claudication (Fontaine stage IIb, pain-free walking distance < 200 m), lasting for at least 3 months to ensure clinical stabilityMedDRA version: 20.0 Level: LLT Classification code 10074576 Term: Peripheral arterial occlusive disease Fontaine stage IIb System Organ Class: 100000004866EUCTR2016-004460-19-DEG. Pohl-Boskamp GmbH & Co.KG100
进行中（未招募）
1 期
A multi-centre, randomized, placebo-controlled, double-blind, parallel-group study investigating safety and efficacy of a sore throat lozenge in the symptomatic treatment of patients with acute pharyngitis.Acute PharyngitisEUCTR2016-003962-24-DEMedice Arzneimittel Pütter GmbH & Co. KG320
进行中（未招募）
1 期
Investigation of the effects of novel medication and its constituents in patients with allergic rhinitis that is not responsive to conventional medicatiorefractory allergic rhinitisMedDRA version: 17.0Level: LLTClassification code 10001723Term: Allergic rhinitisSystem Organ Class: 100000004855EUCTR2013-003096-35-DEuvo Research GmbH